Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
Increasingly powerful genetic technologies are moving us closer to the ability to read and manipulate human genomes not only in somatic cells, but also in germ cells and zygotes. This focus looks at how these technologies are impacting human embryo research and how this may ultimately affect our lives and offspring.
Mitochondrial replacement therapy is being touted as a means of combating maternally inherited disease. But concerns are growing about mitochondrial reversion compromising cures. Steve Connor investigates.
A group of interdisciplinary delegates drawn from the top biotech-producing countries of the world offers a consensus statement outlining a set of principles important to consider in the ethical conversation about human cellular biotechnological research moving forward.
Paul Root Wolpe,
Karen S Rommelfanger &
the Drafting and Reviewing Delegates of the BEINGS Working Groups